Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥54.9bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥113.3bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥49.1bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥1.1bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥777m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥1.4bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥5.8bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.2bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥2.3bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥1.8bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥1.8bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.2bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.8bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥1.2bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥176.2bnat 2023-09-30Cons.Assets
Total assets¥176.0bnat 2023-03-31Cons.Assets
Total assets¥175.5bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥49.9bnat 2023-09-30Cons.Liabilities
Total liabilities¥50.6bnat 2023-03-31Cons.Liabilities
Net assets / equity¥126.2bnat 2023-09-30Cons.Net assets
Net assets / equity¥125.5bnat 2023-03-31Cons.Net assets
Net assets / equity¥124.7bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥26.2bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥19.4bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥25.6bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥18.8bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥27.0bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥26.3bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥8.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥6.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥327m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥6.3bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥3.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥2.0bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥3.4bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥30.662023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥18.852023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥82.442022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.692022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥1.042022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio71.6%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio71.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio71.1%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 447
ItemContextValueUnit
Proceeds from sales of property plant and equipment inv cfCurrentYTDDuration0JPY
Purchase of intangible assets inv cfPrior1YTDDuration-1481000000JPY
Purchase of intangible assets inv cfCurrentYTDDuration-228000000JPY
Purchase of investment securities inv cfPrior1YTDDuration-100000000JPY
Purchase of investment securities inv cfCurrentYTDDuration-0JPY
Proceeds from sales and redemption of investment securities inv cfPrior1YTDDuration551000000JPY
Proceeds from sales and redemption of investment securities inv cfCurrentYTDDuration1968000000JPY
Other net inv cfPrior1YTDDuration-372000000JPY
Other net inv cfCurrentYTDDuration-475000000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-3707000000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration327000000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-100000000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-100000000JPY
Cash dividends paid fin cfPrior1YTDDuration-1855000000JPY
Cash dividends paid fin cfCurrentYTDDuration-1853000000JPY
Other net fin cfPrior1YTDDuration-74000000JPY
Other net fin cfCurrentYTDDuration-66000000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration-2030000000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration-2020000000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration231000000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration95000000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration711000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration6767000000JPY
Cash and cash equivalentsPrior2YearInstant26289000000JPY
Cash and cash equivalentsPrior1YearInstant18816000000JPY
Cash and cash equivalentsPrior1QuarterInstant27001000000JPY
Cash and cash equivalentsCurrentQuarterInstant25584000000JPY
Provision for bonuses sgaPrior1YTDDuration1478000000JPY
Provision for bonuses sgaCurrentYTDDuration1495000000JPY
Retirement benefit expenses sgaPrior1YTDDuration536000000JPY
Retirement benefit expenses sgaCurrentYTDDuration581000000JPY
Research and development expenses sgaPrior1YTDDuration4498000000JPY
Research and development expenses sgaCurrentYTDDuration3842000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-11-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第66期第2四半期(自 2023年7月1日 至 2023年9月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)杏林製薬株式会社
Company name in english cover pageFilingDateInstantKYORIN Pharmaceutical Co., Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長  荻原 豊
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都千代田区神田駿河台四丁目6番地
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03-3525-4700(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)経理財務部長  番場 作郎
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区神田駿河台四丁目6番地
Telephone number nearest place of contact cover pageFilingDateInstant03-3525-4701
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)経理財務部長  番場 作郎
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00985
Fund codeFilingDateInstant-

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass